PABESORAG TAB. 150 MG./12.5 MG. CAJA C/28 (IRBESARTAN-HIDROCLOTIAZIDA) PATENTE Embarazo y lactancia

Description

Embarazo y lactancia

PRINCIPIO ACTIVO: LEVODROPROPICINA

DOSIS: 50/1000 MG

Proteus vulgaris

Cada tableta contiene 5 mg de empagliflozina y 850 mg de metformina

PABESORAG TAB. 150 MG./12.5 MG. CAJA C/28 (IRBESARTAN-HIDROCLOTIAZIDA) PATENTE Embarazo y lactancia

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy